2014-004640-35
Efficacy and Safety of Insulin Glargine Versus. Neutral Protamine Hagedorn (NPH) Insulin in Children With Type 1 Diabetes Above 6 Years Old. (Lantus-P-CN)
Sanofi·EU Clinical Trials Register
Study focus
- Disease/Condition
- Type 1 Diabetes Mellitus
Sponsor & location
- Primary sponsor
- Sanofi
Timeline & enrollment
- Phase
- N/A
- Start date
- N/A
- End date
- N/A
Primary outcome
Treatment with oral or parenteral glucose-lowering medications other than insulin. HbA1c < 7% or > 12 % at screening.
ICD-10 classifications
Type 1 diabetes mellitusType 1 diabetes mellitus with unspecified complicationsType 1 diabetes mellitus with other specified complicationsType 1 diabetes mellitus without complicationsType 1 diabetes mellitus with multiple complications
Data source
- Registry
- EU Clinical Trials Register
- Trial ID
- 2014-004640-35
- Type
- Non-Device Trial
About this record
Access comprehensive clinical trial information for 2014-004640-35 through Pure Global AI's free database. This phase not specified trial is sponsored by Sanofi and is currently status unknown. The study focuses on Type 1 Diabetes Mellitus.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to EU Clinical Trials Register data, helping medical device and pharmaceutical companies navigate clinical research efficiently.